Table 1.
Patient characteristics.
| Control Group (n = 15) |
PECS Group (n = 15) |
p Value | |
|---|---|---|---|
| Age, years | 43 ± 7 | 44 ± 7 | 0.734 |
| BMI, kg/m2 | 22.3 ± 2.9 | 20.7 ± 3.3 | 0.164 |
| ASA physical status | 0.143 | ||
| I | 5 (33%) | 9 (60%) | |
| II | 10 (67%) | 6 (40%) | |
| Smoking history | >0.999 | ||
| Nonsmoker | 14 (93%) | 15 (100%) | |
| Exsmoker | 1 (7%) | 0 (0%) | |
| Menopause status | >0.999 | ||
| Premenopausal | 14 (93%) | 13 (87%) | |
| Postmenopausal | 1 (7%) | 2 (13%) | |
| Motion sickness | 0 (0%) | 5(33%) | 0.042 * |
| PONV history | 0 (0%) | 2 (13%) | 0.483 |
| Neoadjuvant chemotherapy | 4 (27%) | 1 (7%) | 0.330 |
Data are presented as the mean ± standard deviation or number of patients (proportion). BMI, body mass index; ASA, American Society of Anesthesiologists; PONV, postoperative nausea and vomiting; PECS, pectoralis nerve II block. * p < 0.05.